Cdc2 (cdk1) is aberrantly expressed in CML.

被引:0
|
作者
Orr, SJ [1 ]
Lea, NC [1 ]
Mufti, GJ [1 ]
Thomas, SN [1 ]
机构
[1] Kings Coll London, GKT Sch Med, London WC2R 2LS, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4494
引用
收藏
页码:194B / 194B
页数:1
相关论文
共 50 条
  • [31] Cdk1: the dominant sibling of Cdk2
    Bashir, T
    Pagano, M
    NATURE CELL BIOLOGY, 2005, 7 (08) : 779 - 781
  • [32] Cdk1: the dominant sibling of Cdk2
    Tarig Bashir
    Michele Pagano
    Nature Cell Biology, 2005, 7 : 779 - 781
  • [33] Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells
    Jayashree Mitra
    Greg H Enders
    Oncogene, 2004, 23 : 3361 - 3367
  • [34] Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells
    Mitra, J
    Enders, GH
    ONCOGENE, 2004, 23 (19) : 3361 - 3367
  • [35] EFFECTS OF PHOSPHORYLATION BY CAK ON CYCLIN BINDING BY CDC2 AND CDK2
    DESAI, D
    WESSLING, HC
    FISHER, RP
    MORGAN, DO
    MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (01) : 345 - 350
  • [36] Role for Cdk1 (Cdc2)/cyclin A in preventing the mammalian origin recognition complex's largest subunit (Orc1) from binding to chromatin during mitosis
    Li, CJ
    Vassilev, A
    DePamphilis, ML
    MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (13) : 5875 - 5886
  • [37] Mapping the Synthetic Dosage Lethality Network of CDK1/CDC28
    Zimmermann, Christine
    Garcia, Ignacio
    Omerzu, Manja
    Chymkowitch, Pierre
    Zhang, Beibei
    Enserink, Jorrit M.
    G3-GENES GENOMES GENETICS, 2017, 7 (06): : 1753 - 1766
  • [38] Control of Cdc28 CDK1 by a Stress-Induced lncRNA
    Nadal-Ribelles, Mariona
    Sole, Carme
    Xu, Zhenyu
    Steinmetz, Lars M.
    de Nadal, Eulalia
    Posas, Francesc
    MOLECULAR CELL, 2014, 53 (04) : 549 - 561
  • [39] Phospho-p70s6k and cdc2/cdk1 Are Associated with Diffuse Large B-Cell Lymphoma and Are Potential Targets for Combination
    Zhao, M. Y.
    Auerbach, A.
    Costa, A. D.
    Rapoport, A. P.
    Burger, A. M.
    Jiang, F.
    Stass, S. A.
    Sands, A. K.
    Aguilera, N.
    Sausville, E. A.
    Zhao, X. F.
    LABORATORY INVESTIGATION, 2009, 89 : 293A - 293A
  • [40] BUTYROLACTONE-I, A SELECTIVE INHIBITOR OF CDK2 AND CDC2 KINASE
    KITAGAWA, M
    OKABE, T
    OGINO, H
    MATSUMOTO, H
    SUZUKITAKAHASHI, I
    KOKUBO, T
    HIGASHI, H
    SAITOH, S
    TAYA, Y
    YASUDA, H
    OHBA, Y
    NISHIMURA, S
    TANAKA, N
    OKUYAMA, A
    ONCOGENE, 1993, 8 (09) : 2425 - 2432